Paul Goodyer

7.3k total citations · 2 hit papers
137 papers, 5.0k citations indexed

About

Paul Goodyer is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul Goodyer has authored 137 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 45 papers in Pediatrics, Perinatology and Child Health and 38 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul Goodyer's work include Renal and related cancers (49 papers), Biomedical Research and Pathophysiology (20 papers) and Amino Acid Enzymes and Metabolism (20 papers). Paul Goodyer is often cited by papers focused on Renal and related cancers (49 papers), Biomedical Research and Pathophysiology (20 papers) and Amino Acid Enzymes and Metabolism (20 papers). Paul Goodyer collaborates with scholars based in Canada, United States and New Zealand. Paul Goodyer's co-authors include Michael R. Eccles, Elena Torban, Alison Dziarmaga, Sandra Donnelly, Michael Mauer, Diana M. Iglesias, T. Strand, Robert Gardiner, Samy Suissa and Bernard Zinman and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Paul Goodyer

133 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A common molecular basis for three inherited kidney stone diseases

1996 556 citations Paul Goodyer et al. profile →
Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes

2009 514 citations Paul Goodyer et al. profile →

Peers

Countries citing papers authored by Paul Goodyer

Since Specialization

Citations

This map shows the geographic impact of Paul Goodyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Goodyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Goodyer more than expected).

Fields of papers citing papers by Paul Goodyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Goodyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Goodyer. The network helps show where Paul Goodyer may publish in the future.

Co-authorship network of co-authors of Paul Goodyer

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Goodyer. A scholar is included among the top collaborators of Paul Goodyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Goodyer. Paul Goodyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Wilms Tumor Suppressor, WT1, Cooperates with MicroRNA-26a and MicroRNA-101 to Suppress Translation of the Polycomb Protein, EZH2, in Mesenchymal Stem Cells 2016 ·Journal of Biological Chemistry ·(unknown), Diana M. Iglesias, LeeLee Chu, Antonin Thiébaut, (unknown), (unknown), Elena Torban, Paul Goodyer	20
2	Stem Cell Microvesicles Transfer Cystinosin to Human Cystinotic Cells and Reduce Cystine Accumulation In Vitro 2012 ·PLoS ONE ·Diana M. Iglesias, (unknown), Anna Taranta, Francesco Bellomo, Francesco Emma, Martine Besouw, Elena Levtchenko, Jaan Toelen, Lambertus P. van den Heuvel, LeeLee Chu, Jing Zhao, Yoon Kow Young, Nicoletta Eliopoulos, Paul Goodyer	67
3	Lineage Specification of Parietal Epithelial Cells Requires β-Catenin/Wnt Signaling 2011 ·Journal of the American Society of Nephrology ·(unknown), Diana M. Iglesias, Nicolas Wentzensen, Marcus J. Moeller, Maxime Bouchard, Rolf Kemler, Paul Goodyer, Felix Niggli, Hermann-Josef Gröne, Wilhelm Kriz, Robert Koesters	54
4	A Common Variant of the PAX2 Gene Is Associated with Reduced Newborn Kidney Size 2007 ·Journal of the American Society of Nephrology ·Jacklyn Quinlan, Mathieu Lemire, Thomas J. Hudson, Hui‐Qi Qu, Alice Benjamin, Anne Roy, Elena Pascuet, (unknown), (unknown), Zhao Zhang, Fiona J. Houghton, Paul Goodyer	66
5	PAX2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells 2006 ·Kidney International ·Pierre‐Alain Hueber, Paula J. Waters, Philip A. Clarke, Michael R. Eccles, Paul Goodyer	41
6	PAX2 is reactivated in urinary tract obstruction and partially protects collecting duct cells from programmed cell death 2006 ·American Journal of Physiology-Renal Physiology ·(unknown), Oleg Loutochin, (unknown), John-Paul Capolicchio, Paul Goodyer, Roman Jednak	24
7	Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease 2006 ·Human Molecular Genetics ·Cherie Stayner, Diana M. Iglesias, Paul Goodyer, (unknown), Gregory G. Germino, Jing Zhou, Michael R. Eccles	32
8	First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future 2005 ·Pediatric Nephrology ·Robert Kleta, Frederick J. Kaskel, Ranjan Dohil, Paul Goodyer, Lisa M. Guay‐Woodford, Erik Harms, Julie R. Ingelfinger, Vera Hermina Kalika Koch, Craig B. Langman, Mary B. Leonard, Roslyn B. Mannon, Minnie Sarwal, Jerry A. Schneider, Flemming Skovby, Barbara C. Sonies, Jess G. Thoene, Doris A. Trauner, William A. Gahl	21
9	The safety and use of short-acting nifedipine in hospitalized hypertensive children 2004 ·Pediatric Nephrology ·Verna Yiu, Elaine Orrbine, Rhonda J. Rosychuk, (unknown), Paul Goodyer, (unknown), Manjula Gowrishankar, Malcolm R. Ogborn, Julian Midgley, Guido Filler, Frances Harley	24
10	WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2 2003 ·Oncogene ·(unknown), Shujie He, Tae Ho Lee, Lee Lee Chu, Brad Bolon, Paul Goodyer, Michael R. Eccles, Jerry Pelletier	32
11	Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival 2003 ·Oncogene ·(unknown), Chaoming Zhou, (unknown), Paul Goodyer, Michael R. Eccles	197
12	SLC7A9 mutations in all three cystinuria subtypes 2002 ·Kidney International ·Daniel Leclerc, Marylise Boutros, (unknown), Qing Wu, Manuel Palacı́n, James Ellis, Paul Goodyer, Rima Rozen	38
13	Two novel 1α-hydroxylase mutations in French-Canadians with vitamin D dependency rickets type I 1998 ·Kidney International ·Tadashi Yoshida, Toshiaki Monkawa, Harriet S. Tenenhouse, Paul Goodyer, Toshimasa Shinki, (unknown), Shu Wakino, Matsuhiko Hayashi, Takao Saruta	51
14	Cystinuria subtype and the risk of nephrolithiasis 1998 ·Kidney International ·Paul Goodyer, Irfan Saadi, (unknown), (unknown), Rima Rozen	63
15	Mutational analyses in Gitelman syndrome 1996 ·Journal of the American Society of Nephrology ·Lambert P.W.J. van den Heuvel, Henny H. Lemmink, (unknown), (unknown), Patrick Niaudet, Lisa M. Guay‐Woodford, Paul Goodyer, (unknown), Steven Hébert, Nine V.A.M. Knoers	1
16	Molecular genetics of cystinuria in French Canadians: Identification of four novel mutations in Type I patients 1996 ·Kidney International ·(unknown), Irfan Saadi, John Raelson, Paul Goodyer, Rima Rozen	34
17	Assignment of the Gene for Cystinuria (SLC3A1) to Human Chromosome 2p21 by Fluorescence in Situ Hybridization 1994 ·Genomics ·Xiaoxiang Zhang, Rima Rozen, Matthias A. Hediger, Paul Goodyer, Patrice Eydoux	29
18	Renal synthesis of epidermal growth factor is unchanged by vitamin D deficiency 1990 ·Canadian Journal of Physiology and Pharmacology ·Paul Goodyer, (unknown), (unknown)	1
19	Respiratory chain defects in the mitochondria of cultured skin fibroblasts from three patients with lacticacidemia. 1986 ·Journal of Clinical Investigation ·B. H. Robinson, Jeremy Ward, Paul Goodyer, (unknown)	79
20	Hypernatremia in seborrheic dermatitis 1978 ·The Journal of Pediatrics ·(unknown), Paul Goodyer, Bernard S. Kaplan	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact